New Paradigm in the Role of Regulatory T Cells During Pregnancy

Sayaka Tsuda, Akitoshi Nakashima, Tomoko Shima, Shigeru Saito, Sayaka Tsuda, Akitoshi Nakashima, Tomoko Shima, Shigeru Saito

Abstract

Semi-allogenic fetuses are not rejected by the maternal immune system because feto-maternal tolerance induced by CD4+CD25+FoxP3+ regulatory T (Treg) cells is established during pregnancy. Paternal antigen-specific Treg cells accumulate during pregnancy, and seminal plasma priming plays an important role in expanding paternal antigen-specific Treg cells in mouse models. Although paternal-antigen specific Treg cells have not been identified in humans, recent studies suggest that antigen-specific Treg cells exist and expand at the feto-maternal interface in humans. Studies have also revealed that reduction of decidual functional Treg cells occurs during miscarriage with normal fetal chromosomal content, whereas insufficient clonal expansion of decidual Treg cells is observed in preeclampsia. In this review, we will discuss the recent advances in the investigation of mechanisms underlying Treg cell-dependent maintenance of feto-maternal tolerance.

Keywords: miscarriage; preeclampsia; pregnancy; regulatory T cells; seminal plasma.

Figures

Figure 1
Figure 1
Immunological balance at the feto-maternal interface during early pregnancy. EVTs did not express polymorphic HLA-A, B whereas HLA-C and non-polymorphic HLA-E, G, and F were expressed. Maternal CD8+ T cells and NK cells can directly recognize paternal HLA-C and CD4+ T cells can indirectly recognize it. HLA- E and G protect EVTs from NK-cell mediated cytotoxicity. Treg cells can recognize fetal antigens via maternal antigen presenting cells (APCs) and induce tolerance in an antigen-specific manner. EVT, Extravillous trophoblast; NK, natural killer cell; Treg; regulatory T cell; APC, antigen-presenting cell.
Figure 2
Figure 2
Distribution of paternal antigen-specific Treg cells in mice. When a female mouse is mated with an allogenic male mouse, paternal antigen-specific Treg cells increase in the uterine-draining lymph nodes one day before implantation due to seminal plasma priming. After implantation, the paternal antigen-specific Treg cells population in the uterus increases day by day during the course of the pregnancy, but not in the peripheral lymph nodes and the spleen. APC, antigen-presenting cell.
Figure 3
Figure 3
Single-cell based TCR repertoire analysis method. To study the clonality of effector Treg cells, a single-cell based T cell receptor (TCR) repertoire analysis method was used. Paired samples of maternal peripheral blood mononuclear cells and decidual lymphocytes were obtained. CD4+CD25+CD45RA-CD127low/- effector Treg cells were single-cell sorted. The cDNAs of complementarity determining lesion 3 (CDR3) in TCRβ chain and FoxP3 were amplified by RT-PCR. The nucleotides and amino acid sequences of CDR3 were analyzed.
Figure 4
Figure 4
Distribution of clonally expanded effector Treg cells in humans. (A) Frequencies of total Treg cells, effector Treg cells and clonal populations of effector Treg cells in normal pregnancy. The systemic and local expansion of the Treg cells and effector Treg cells pool is observed during pregnancies in humans. Clonally expanded effector Treg cells increase in decidua, but not in peripheral blood. Clonal populations of effector Treg cells more increase in 3rd trimester than 1st trimester. (B) Clonally expanded decidual effector Treg cells in miscarriage and preeclampsia. In decidua, effector Treg cells pool decreased in miscarriage with normal chromosomal content than 1st trimester normal pregnancy, whereas the frequency of clonal populations of effector Treg cells does not significantly decrease. On the other hand, clonal populations of decidual effector Treg cells decreased preeclampsia than 3rd trimester normal pregnancies.
Figure 5
Figure 5
Pathological change in Treg cells during pregnancy in humans. During pregnancy, Treg cell pools both in the peripheral blood and decidua expand. Clonally expanded effector Treg cells are observed only in the decidua, but not in the peripheral blood. Clonally expanded effector Treg cells are higher in the 3rd trimester than in the 1st trimester. In miscarriage cases with normal chromosomal fetal content, the number of decidual effector Treg cells decreases. On the other hand, clonal populations of decidual effector Treg cells decrease in cases of preeclampsia.

References

    1. Saito S, Shima T, Nakashima A, Shiozaki A, Ito M, Sasaki Y. What is the role of regulatory T cells in the success of implantation and early pregnancy? J Assist Reprod Genet. (2007) 24:379–86. 10.1007/s10815-007-9140-y
    1. Erlebacher A. Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol. (2013) 13:23–33. 10.1038/nri3361
    1. Robertson SA, Prins JR, Sharkey DJ, Moldenhauer LM. Seminal fluid and the generation of regulatory T cells for embryo implantation. Am J Reprod Immunol. (2013) 69:315–30. 10.1111/aji.12107
    1. Zenclussen AC. Adaptive immune responses during pregnancy. Am J Reprod Immunol. (2013) 69:291–303. 10.1111/aji.12097
    1. PrabhuDas M, Bonney E, Caron K, Dey SCA, Fazleabas A, et al. . Immune mechanisms at the maternal-fetal interface: perspectives and challenges. Nat Immunol. (2015) 16:328–34. 10.1038/ni.3131
    1. Saito S, Nakabayashi Y, Nakashima A, Shima T, Yoshino O. A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health. Semin Immunopathol. (2016) 38:687–97. 10.1007/s00281-016-0577-x
    1. Saito S, Shima T, Nakashima A, Inada K, Yoshino O. Role of paternal antigen-specific treg cells in successful implantation. Am J Reprod Immunol. (2016) 75:310–6. 10.1111/aji.12469
    1. Saito S, Nishikawa K, Morii T, Narita N, Enomoto M, Ichijo M. Expression of activation antigens CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2R alpha) and IL-2R beta on T cells of human decidua at an early stage of pregnancy. Immunology. (1992) 75:710–2.
    1. Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter T, et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+ CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol. (2005) 166:811–22. 10.1016/S0002-9440(10)62302-4
    1. Shima T, Sasaki Y, Itoh M, Nakashima A, Ishii N, Sugamura K, et al. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J Reprod Immunol. (2010) 85:121–9. 10.1016/j.jri.2010.02.006
    1. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. (2004) 5:266–71. 10.1038/ni1037
    1. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod. (2004) 10:347–53. 10.1093/molehr/gah044
    1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. (1995) 155:1151–64.
    1. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. (2008) 133:775–87. 10.1016/j.cell.2008.05.009
    1. Kahn DA, Baltimore D. Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance. Proc Natl Acad Sci USA. (2010) 107:9299–304. 10.1073/pnas.1003909107
    1. Rowe JH, Ertelt JM, Xin L, Way SS. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature. (2012) 490:102–6. 10.1038/nature11462
    1. Shima T, Inada K, Nakashima A, Ushijima A, Ito M, Yoshino O, et al. . Paternal antigen-specific proliferating regulatory T cells are increased in uterine-draining lymph nodes just before implantation and in pregnant uterus just after implantation by seminal plasma-priming in allogeneic mouse pregnancy. J Reprod Immunol. (2015) 108:72–82. 10.1016/j.jri.2015.02.005
    1. Robertson SA, Guerin LR, Bromfield JJ, Branson KM, Ahlstrom AC, Care AS. Seminal fluid drives expansion of the CD4+ CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod. (2009) 80:1036–45. 10.1095/biolreprod.108.074658
    1. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. (2004) 112:38–43. 10.1111/j.1365-2567.2004.01869.x
    1. Tsuda S, Zhang X, Hamana H, Shima T, Ushijima A, Tsuda K, et al. Clonally expanded decidual effector regulatory T cells increase in late gestation of normal pregnancy, but not in preeclampsia, in humans. Front Immunol. (2018) 9:1934 10.3389/fimmu.2018.01934
    1. Fisher SJ, Damsky CH. Human cytotrophoblast invasion. Semin Cell Biol. (1993) 4:183–8. 10.1006/scel.1993.1022
    1. Fisher SJ. Why is placentation abnormal in preeclampsia? Am J Obstet Gynecol. (2015) 213:S115–22. 10.1016/j.ajog.2015.08.042
    1. Wallace AE, Fraser R, Cartwright JE. Extravillous trophoblast and decidual natural killer cells: a remodelling partnership. Hum Reprod Update. (2012) 18:458–71. 10.1093/humupd/dms015
    1. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science. (1990) 248:220–3. 10.1126/science.2326636
    1. McMaster MT, Librach CL, Zhou Y, Lim KH, Janatpour MJ, DeMars R, et al. . Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol. (1995) 154:3771–8.
    1. King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, et al. . HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol. (2000) 30:1623–31. 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>;2-M
    1. King A, Burrows TD, Hiby SE, Bowen JM, Joseph S, Verma S, et al. . Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta. (2000) 21:376–87. 10.1053/plac.1999.0496
    1. Barakonyi A, Kovacs KT, Miko E, Szereday L, Varga P, Szekeres-Bartho J. Recognition of nonclassical HLA class I antigens by gamma delta T cells during pregnancy. J Immunol. (2002) 168:2683–8. 10.4049/jimmunol.168.6.2683
    1. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, et al. . Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol. (2003) 171:1376–84. 10.4049/jimmunol.171.3.1376
    1. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med. (1999) 189:1093–100. 10.1084/jem.189.7.1093
    1. Li C, Houser BL, Nicotra ML, Strominger JL. HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc Natl Acad Sci USA. (2009) 106:5767–72. 10.1073/pnas.0901173106
    1. Ristich V, Liang S, Zhang W, Wu J, Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol. (2005) 35:1133–42. 10.1002/eji.200425741
    1. Tilburgs T, Crespo AC, van der Zwan A, Rybalov B, Raj T, Stranger B, et al. . Human HLA-G+ extravillous trophoblasts: Immune-activating cells that interact with decidual leukocytes. Proc Natl Acad Sci USA. (2015) 112:7219–24. 10.1073/pnas.1507977112
    1. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, et al. . Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. (1998) 281:1191–3. 10.1126/science.281.5380.1191
    1. Chang RQ, Li DJ, Li MQ. The role of indoleamine-2,3-dioxygenase in normal and pathological pregnancies. Am J Reprod Immunol. (2018) 79:e12786. 10.1111/aji.12786
    1. Guzeloglu-Kayisli O, Kayisli UA, Taylor HS. The role of growth factors and cytokines during implantation: endocrine and paracrine interactions. Semin Reprod Med. (2009) 27:62–79. 10.1055/s-0028-1108011
    1. Nagamatsu T, Schust DJ, Sugimoto J, Barrier BF. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions. Hum Reprod. (2009) 24:3160–71. 10.1093/humrep/dep308
    1. King A, Wooding P, Gardner L, Loke YW. Expression of perforin, granzyme A and TIA-1 by human uterine CD56+ NK cells implies they are activated and capable of effector functions. Hum Reprod. (1993) 8:2061–7. 10.1093/oxfordjournals.humrep.a137982
    1. Higuma-Myojo S, Sasaki Y, Miyazaki S, Sakai M, Siozaki A, Miwa N, et al. . Cytokine profile of natural killer cells in early human pregnancy. Am J Reprod Immunol. (2005) 54:21–9. 10.1111/j.1600-0897.2005.00279.x
    1. Saito S, Nakashima A, Myojo-Higuma S, Shiozaki A. The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J Reprod Immunol. (2008) 77:14–22. 10.1016/j.jri.2007.04.007
    1. Moffett A, Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest. (2014) 124:1872–9. 10.1172/JCI68107
    1. Saito S, Nishikawa K, Morii T, Enomoto M, Narita N, Motoyoshi K, et al. . Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Int Immunol. (1993) 5:559–63. 10.1093/intimm/5.5.559
    1. King A, Birkby C, Loke YW. Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell Immunol. (1989) 118:337–44. 10.1016/0008-8749(89)90382-1
    1. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. . Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. (2006) 12:1065–74. 10.1038/nm1452
    1. Lash GE, Schiessl B, Kirkley M, Innes BA, Cooper A, Searle RF, et al. . Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol. (2006) 80:572–80. 10.1189/jlb.0406250
    1. Pollheimer J, Vondra S, Baltayeva J, Beristain AG, Knofler M. Regulation of placental extravillous trophoblasts by the maternal uterine environment. Front Immunol. (2018) 9:2597. 10.3389/fimmu.2018.02597
    1. Cerdeira AS, Rajakumar A, Royle CM, Lo A, Husain Z, Thadhani RI, et al. . Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors. J Immunol. (2013) 190:3939–48. 10.4049/jimmunol.1202582
    1. Lissauer D, Piper K, Goodyear O, Kilby MD, Moss PA. Fetal-specific CD8+ cytotoxic T cell responses develop during normal human pregnancy and exhibit broad functional capacity. J Immunol. (2012) 189:1072–80. 10.4049/jimmunol.1200544
    1. Tilburgs T, Strominger JL. CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity. Am J Reprod Immunol. (2013) 69:395–407. 10.1111/aji.12094
    1. van Egmond A, van der Keur C, Swings GM, Scherjon SA, Claas FH. The possible role of virus-specific CD8(+) memory T cells in decidual tissue. J Reprod Immunol. (2016) 113:1–8. 10.1016/j.jri.2015.09.073
    1. van der Zwan A, van der Meer-Prins EMW, van Miert P, van den Heuvel H, Anholts JDH, Roelen DL, et al. . Cross-reactivity of virus-specific CD8+ T cells against allogeneic HLA-C: possible implications for pregnancy outcome. Front Immunol. (2018) 9:2880. 10.3389/fimmu.2018.02880
    1. Wang SC, Li YH, Piao HL, Hong XW, Zhang D, Xu YY, et al. . PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy. Cell Death Dis. (2015) 6:e1738. 10.1038/cddis.2015.112
    1. Tilburgs T, Schonkeren D, Eikmans M, Nagtzaam NM, Datema G, Swings GM, et al. . Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties. J Immunol. (2010) 185:4470–77. 10.4049/jimmunol.0903597
    1. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science. (1995) 270:630–3. 10.1126/science.270.5236.630
    1. Bacher P, Scheffold A. New technologies for monitoring human antigen-specific T cells and regulatory T cells by flow-cytometry. Curr Opin Pharmacol. (2015) 23:17–24. 10.1016/j.coph.2015.04.005
    1. Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Kleijburg C, Scherjon SA, et al. Evidence for a selective migration of fetus-specific CD4+ CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol. (2008) 180:5737–45. 10.4049/jimmunol.180.8.5737
    1. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, et al. . Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. (2009) 30:899–911. 10.1016/j.immuni.2009.03.019
    1. Miyara M, Chader D, Sage E, Sugiyama D, Nishikawa H, Bouvry D, et al. . Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3high regulatory T cells in humans. Proc Natl Acad Sci USA. (2015) 112:7225–30. 10.1073/pnas.1508224112
    1. Loewendorf AI, Nguyen TA, Yesayan MN, Kahn DA. Normal human pregnancy results in maternal immune activation in the periphery and at the uteroplacental interface. PLoS ONE. (2014) 9:e96723. 10.1371/journal.pone.0096723
    1. Qi Q, Liu Y, Cheng Y, Glanville J, Zhang D, Lee JY, et al. . Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci USA. (2014) 111:13139–44. 10.1073/pnas.1409155111
    1. Kinder JM, Jiang TT, Ertelt JM, Xin L, Strong BS, Shaaban AF, et al. . Cross-generational reproductive fitness enforced by microchimeric maternal cells. Cell. (2015) 162:505–15. 10.1016/j.cell.2015.07.006
    1. Burlingham WJ, Grailer AP, Heisey DM, Claas FH, Norman D, Mohanakumar T, et al. . The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med. (1998) 339:1657–64. 10.1056/NEJM199812033392302
    1. van Rood JJ, Claas F. Both self and non-inherited maternal HLA antigens influence the immune response. Immunol Today. (2000) 21:269–73. 10.1016/S0167-5699(00)01628-5
    1. van Rood JJ, Loberiza FRJr, Zhang MJ, Oudshoorn M, Claas F, Cairo MS, et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood. (2002) 99:1572–7. 10.1182/blood.V99.5.1572
    1. Nijagal A, Fleck S, MacKenzie TC. Maternal microchimerism in patients with biliary atresia: implications for allograft tolerance. Chimerism. (2012) 3:37–9. 10.4161/chim.20152
    1. Tilburgs T, Scherjon SA, van der Mast BJ, Haasnoot GW, Versteeg VDV-MM, Roelen DL, et al. . Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J Reprod Immunol. (2009) 82:148–57. 10.1016/j.jri.2009.05.003
    1. Lashley LE, Haasnoot GW, Spruyt-Gerritse M, Claas FH. Selective advantage of HLA matching in successful uncomplicated oocyte donation pregnancies. J Reprod Immunol. (2015) 112:29–33. 10.1016/j.jri.2015.05.006
    1. Ranella A, Vassiliadis S, Mastora C, Valentina M, Dionyssopoulou E, Athanassakis I. Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells. Hum Immunol. (2005) 66:43–55. 10.1016/j.humimm.2004.10.002
    1. Tersigni C, Redman CW, Dragovic R, Tannetta D, Scambia G, Di Simone N, et al. HLA-DR is aberrantly expressed at fetomaternal interface in pre-eclampsia. J Reprod Immunol. (2018) 129:48–52. 10.1016/j.jri.2018.06.024
    1. Koelman CA, Coumans AB, Nijman HW, Doxiadis II, Dekker GA, Claas FH. Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid? J Reprod Immunol. (2000) 46:155–66. 10.1016/S0165-0378(99)00062-5
    1. Larsen MH, Bzorek M, Pass MB, Larsen LG, Nielsen MW, Svendsen SG, et al. . Human leukocyte antigen-G in the male reproductive system and in seminal plasma. Mol Hum Reprod. (2011) 17:727–38. 10.1093/molehr/gar052
    1. Craenmehr MH, Heidt S, Eikmans M, Claas FH. What is wrong with the regulatory T cells and foetomaternal tolerance in women with recurrent miscarriages? Hla. (2016) 87:69–78. 10.1111/tan.12737
    1. Linscheid C, Petroff MG. Minor histocompatibility antigens and the maternal immune response to the fetus during pregnancy. Am J Reprod Immunol. (2013) 69:304–14. 10.1111/aji.12075
    1. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. . Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. (2003) 198:1875–86. 10.1084/jem.20030152
    1. Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell. (2012) 150:29–38. 10.1016/j.cell.2012.05.031
    1. Inada K, Shima T, Ito M, Ushijima A, Saito S. Helios-positive functional regulatory T cells are decreased in decidua of miscarriage cases with normal fetal chromosomal content. J Reprod Immunol. (2015) 107:10–9. 10.1016/j.jri.2014.09.053
    1. Hsu P, Santner-Nanan B, Dahlstrom JE, Fadia M, Chandra A, Peek M, et al. . Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am J Pathol. (2012) 181:2149–60. 10.1016/j.ajpath.2012.08.032
    1. Zhou J, Wang Z, Zhao X, Wang J, Sun H, Hu Y. An increase of Treg cells in the peripheral blood is associated with a better in vitro fertilization treatment outcome. Am J Reprod Immunol. (2012) 68:100–6. 10.1111/j.1600-0897.2012.01153.x
    1. Jasper MJ, Tremellen KP, Robertson SA. Primary unexplained infertility is associated with reduced expression of the Tregulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod. (2006) 12:301–8. 10.1093/molehr/gal032
    1. Lu Y, Zhang F, Zhang Y, Zeng B, Hu L, Liao A. Quantitative reduction of peripheral CD4+ CD25+ FOXP3+ regulatory T cells in reproductive failure after artificial insemination by donor sperm. Am J Reprod Immunol. (2013) 69:188–93. 10.1111/aji.12041
    1. Tremellen KP, Valbuena D, Landeras J, Ballesteros A, Martinez J, Mendoza S, et al. . The effect of intercourse on pregnancy rates during assisted human reproduction. Hum Reprod. (2000) 15:2653–8. 10.1093/humrep/15.12.2653
    1. Yang H, Qiu L, Chen G, Ye Z, Lu C, Lin Q. Proportional change of CD4+ CD25+ regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients. Fertil Steril. (2008) 89:656–61. 10.1016/j.fertnstert.2007.03.037
    1. Mei S, Tan J, Chen H, Chen Y, Zhang J. Changes of CD4+ CD25high regulatory T cells and FOXP3 expression in unexplained recurrent spontaneous abortion patients. Fertil Steril. (2010) 94:2244–7. 10.1016/j.fertnstert.2009.11.020
    1. Wang WJ, Hao CF, Yi L, Yin GJ, Bao SH, Qiu LH, et al. . Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol. (2010) 84:164–70. 10.1016/j.jri.2009.12.003
    1. Jin LP, Chen QY, Zhang T, Guo PF, Li DJ. The CD4+CD25 bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage. Clin Immunol. (2009) 133:402–10. 10.1016/j.clim.2009.08.009
    1. Wang WJ, Hao CF, Qu QL, Wang X, Qiu LH, Lin QD. The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Hum Reprod. (2010) 25:2591–6. 10.1093/humrep/deq198
    1. Liu C, Wang XZ, Sun XB. Assessment of sperm antigen specific T regulatory cells in women with recurrent miscarriage. Early Hum Dev. (2013) 89:95–100. 10.1016/j.earlhumdev.2012.08.003
    1. Arruvito L, Sotelo AI, Billordo A, Fainboim L. A physiological role for inducible FOXP3(+) Treg cells. Lessons from women with reproductive failure. Clin Immunol. (2010) 136:432–41. 10.1016/j.clim.2010.05.002
    1. Inada K, Shima T, Nakashima A, Aoki K, Ito M, Saito S. Characterization of regulatory T cells in decidua of miscarriage cases with abnormal or normal fetal chromosomal content. J Reprod Immunol. (2013) 97:104–11. 10.1016/j.jri.2012.12.001
    1. Yamada H, Takeda M, Maezawa Y, Ebina Y, Hazama R, Tanimura K, et al. A high dose intravenous immunoglobulin therapy for women with four or more recurrent spontaneous abortions. ISRN Obstet Gynecol. (2012) 2012:512732 10.5402/2012/512732
    1. Winger EE, Reed JL. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol. (2008) 60:8–16. 10.1111/j.1600-0897.2008.00585.x
    1. Wong LF, Porter TF, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. (2014) Cd000112. 10.1002/14651858.CD000112.pub3
    1. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. (1999) 180(Pt 1):499–506.
    1. Robillard PY, Hulsey TC, Alexander GR, Keenan A, de Caunes F, Papiernik E. Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J Reprod Immunol. (1993) 24:1–12.
    1. Trupin LS, Simon LP, Eskenazi B. Change in paternity: a risk factor for preeclampsia in multiparas. Epidemiology. (1996) 7:240–4.
    1. Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med. (2002) 346:33–8. 10.1056/NEJMoa011379
    1. Klonoff-Cohen HS, Savitz DA, Cefalo RC, McCann MF. An epidemiologic study of contraception and preeclampsia. JAMA. (1989) 262:3143–7.
    1. Salha O, Sharma V, Dada T, Nugent D, Rutherford AJ, Tomlinson AJ, et al. . The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod. (1999) 14:2268–73.
    1. Darmochwal-Kolarz D, Saito S, Rolinski J, Tabarkiewicz J, Kolarz B, Leszczynska-Gorzelak B, et al. . Activated T lymphocytes in pre-eclampsia. Am J Reprod Immunol. (2007) 58:39–45. 10.1111/j.1600-0897.2007.00489.x
    1. Sasaki Y, Darmochwal-Kolarz D, Suzuki D, Sakai M, Ito M, Shima T, et al. . Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin Exp Immunol. (2007) 149:139–45. 10.1111/j.1365-2249.2007.03397.x
    1. Toldi G, Svec P, Vasarhelyi B, Meszaros G, Rigo J, Tulassay T, et al. . Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstet Gynecol Scand. (2008) 87:1229–33. 10.1080/00016340802389470
    1. Miko E, Szereday L, Barakonyi A, Jarkovich A, Varga P, Szekeres-Bartho A. Immunoactivation in preeclampsia: Vd2+ and regulatory T cells during the inflammatory stage of disease. J Reprod Immunol. (2009) 80:100–8. 10.1016/j.jri.2009.01.003
    1. Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B, et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol. (2009) 183:7023–30. 10.4049/jimmunol.0901154
    1. Toldi G, Rigo J, Jr, Stenczer B, Vasarhelyi B, Molvarec A. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am J Reprod Immunol. (2011) 66:223–9. 10.1111/j.1600-0897.2011.00987.x
    1. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, et al. . The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol. (2012) 93:75–81. 10.1016/j.jri.2012.01.006
    1. Zeng B, Kwak-Kim J, Liu Y, Liao AH. Treg cells are negatively correlated with increased memory B cells in pre-eclampsia while maintaining suppressive function on autologous B-cell proliferation. Am J Reprod Immunol. (2013) 70:454–63. 10.1111/aji.12154
    1. Moreno-Eutimio MA, Tovar-Rodriguez JM, Vargas-Avila K, Nieto-Velazquez NG, Frias-De-Leon MG, Sierra-Martinez M, et al. . Increased serum levels of inflammatory mediators and low frequency of regulatory T cells in the peripheral blood of preeclamptic Mexican women. Biomed Res Int. (2014) 2014:413249. 10.1155/2014/413249
    1. Toldi G, Vasarhelyi ZE, Rigo J, Jr, Orban C, Tamassy Z, Bajnok A, et al. . Prevalence of Regulatory T-Cell Subtypes in Preeclampsia. Am J Reprod Immunol. (2015) 74:110–15. 10.1111/aji.12380.
    1. Darmochwal-Kolarz D, Saito S, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, et al. Apoptosis signaling is altered in CD4(+)CD25(+)FoxP3(+) T regulatory lymphocytes in pre-eclampsia. Int J Mol Sci. (2012) 13:6548–60. 10.3390/ijms13066548

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다